Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Food, Beverages & Tobacco | Small Cap
Health Score : 8.44Nirman Agri Genetics Ltd demonstrates a strong financial standing within the FMCG sector. The company shows excellent liquidity, driven by its ability to meet short-term obligations. It maintains a solid solvency position with low debt levels, indicating financial stability. The company has experienced remarkable growth in revenue, operating profit, and earnings per share, reflecting effective management and market demand. Profitability ratios are also strong, showcasing the ability to generate profits from its operations. However, it's important to note the company's low coverage ratios, suggesting potential vulnerability if interest expenses were to arise. Additionally, efficiency ratios reveal some areas for improvement, particularly in managing capital turnover and receivable days. Overall, Nirman Agri Genetics Ltd presents a promising financial profile, marked by robust growth and profitability, balanced by areas requiring attention in efficiency and coverage.
Health Score : 8.44Nirman Agri Genetics Ltd demonstrates a strong financial standing within the FMCG sector. The company shows excellent liquidity, driven by its ability to meet short-term obligations. It maintains a solid solvency position with low debt levels, indicating financial stability. The company has experienced remarkable growth in revenue, operating profit, and earnings per share, reflecting effective management and market demand. Profitability ratios are also strong, showcasing the ability to generate profits from its operations. However, it's important to note the company's low coverage ratios, suggesting potential vulnerability if interest expenses were to arise. Additionally, efficiency ratios reveal some areas for improvement, particularly in managing capital turnover and receivable days. Overall, Nirman Agri Genetics Ltd presents a promising financial profile, marked by robust growth and profitability, balanced by areas requiring attention in efficiency and coverage.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
1.30
Industry Median
26.10
Small Cap Median
23.99
P/E RATIO
1.30
P/B RATIO
0.18
Industry Median
2.24
Small Cap Median
2.01
P/S RATIO
N/A
Industry Median
3.66
Small Cap Median
3.20
Others
PEG RATIO
0.00
EV/EBITDA RATIO
0.00
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹28.55 as on Sep 1, 2026.
Growth Score : 10.00The company exhibits strong growth across all key metrics, including revenue, operating profit, earnings per share, assets, and net income. This indicates robust expansion and suggests effective management strategies. The company's commitment to innovation and market penetration is driving significant financial success. This consistent growth positions the company favorably for future opportunities and increased market share.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 123.08 | 117.24 | 276.19 | -16.88 |
| Operating Profit Growth Rate | 33.33 | 175 | 145.45 | -29.63 |
| Earnings Per Share (EPS) Growth | 159.48 | 142.85 | -30.35 | |
| Asset Growth Rate | 400 | 46.67 | 156.82 | 14.16 |
| Net Income Growth Rate | 33.33 | 150 | 150 | -28 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Nirman Agri Genetics Ltd | 8.44 | 1.30 | Neutral | 19.00 | 21.98 | 18.00 |
| 2 | Continental Seeds and Chemicals Ltd | 7.76 | 16.18 | Highly Undervalued | 2.99 | 0.72 | 1.01 |
| 3 | Sameera Agro and Infra Ltd | 7.39 | 1.93 | Neutral | 25.00 | 2.80 | 15.00 |
| 4 | Vishwas Agri Seeds Ltd | 4.77 | 25.21 | Neutral | 9.00 | 2.14 | 2.00 |
| 5 | RAVALSUGAR | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Nirman Agri Genetics Ltd. is an Indian agricultural input company engaged in research, production, processing, and marketing of high-quality seeds. They specialize in crop seeds including cereals, pulses, vegetables, and fodder, serving farmers across various regions. The company aims to enhance agricultural productivity and farmer profitability through advanced genetic research and sustainable practices.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Nirman Agri Genetics Ltd's P/E ratio (TTM) is 1.30, compared to the industry median of 26.10 and large cap median of 23.99.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Nirman Agri Genetics Ltd's P/B ratio is 0.18, compared to the industry median of 2.24 and large cap median of 2.01.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Nirman Agri Genetics Ltd's P/S ratio is 10.90, compared to the industry median of 3.66 and large cap median of 3.20.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Nirman Agri Genetics Ltd's PEG ratio is 2.50.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Nirman Agri Genetics Ltd's EV/EBITDA ratio is 59.60.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Nirman Agri Genetics Ltd's ROE is 14.06%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Nirman Agri Genetics Ltd's ROA is 14.73%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Nirman Agri Genetics Ltd's ROCE is 15%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Nirman Agri Genetics Ltd's operating margin is 9.64%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Nirman Agri Genetics Ltd's net margin is 9.14%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Nirman Agri Genetics Ltd's current ratio is 57.66.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Nirman Agri Genetics Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Nirman Agri Genetics Ltd's interest coverage ratio is N/A.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Nirman Agri Genetics Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Nirman Agri Genetics Ltd's EPS is -30.35.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹28.55. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2022
Headquarters: Nagpur, Maharashtra
Core Offerings: Hybrid Seeds, Open Pollinated Variety Seeds, Fodder Seeds, Agri-input Products
Stock Listing: NSE (NIRMAN), BSE ({bse})
Promoter: Dr. Pradip Vasudeo Kakade, Buty Family
2022: Incorporated as Nirman Agri Genetics Limited on October 18, 2022.
2023: Successfully launched an Initial Public Offering (IPO) and listed on NSE Emerge, marking its public market debut.
Present: Continues to focus on agricultural seed development, production, and marketing, expanding its product portfolio and market reach in India.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| N/A | N/A | Operating Profit |
Seed Research & Development: Focuses on developing new, high-yielding, and disease-resistant hybrid and open-pollinated varieties of various crops suitable for diverse agro-climatic zones.
Seed Production & Processing: Engages in contract farming for seed production, followed by in-house processing (cleaning, grading, treating) and packaging to ensure quality and germination standards.
Marketing & Distribution: Operates a wide distribution network to supply its seed products to farmers through distributors and dealers across key agricultural states in India.
Dr. Pradip Vasudeo Kakade: Chairman & Managing Director. He is an agricultural scientist with extensive experience in seed breeding and the agri-biotechnology sector, guiding the company's research and strategic direction.
No major subsidiaries reported.
No major recent corporate actions on record.
The Nirman Agri Genetics Ltd share price today is ₹28.55 on NSE (NIRMAN), as of 23 Oct 2026.
As of 23 Oct 2026, Nirman Agri Genetics Ltd share price is ₹28.55, with previous close ₹28.55. Today's range is ₹28.55 to ₹28.55. The 52-week range is ₹N/A to ₹N/A.
As of today, Nirman Agri Genetics Ltd's market cap is ₹0 crore (Small Cap).
Nirman Agri Genetics Ltd's current P/E ratio is 1.30, compared to the REALTY sector average of 53.50.
Nirman Agri Genetics Ltd's current P/B ratio is 0.18.
Nirman Agri Genetics Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Nirman Agri Genetics Ltd's EPS (TTM) is ₹-30.35.
Nirman Agri Genetics Ltd. is an Indian agricultural input company engaged in research, production, processing, and marketing of high-quality seeds. They specialize in crop seeds including cereals, pulses, vegetables, and fodder, serving farmers across various regions. The company aims to enhance agricultural productivity and farmer profitability through advanced genetic research and sustainable practices.
Nirman Agri Genetics Ltd is promoted by Dr. Pradip Vasudeo Kakade, Buty Family, holding 44.34% as of 23 Oct 2026.
Nirman Agri Genetics Ltd is listed on NSE (NIRMAN) and BSE ({bse}). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Book Value Per Share
Dividend Per Share (DPS)
Inventory Turnover Ratio